UniProt ID | PAPS1_HUMAN | |
---|---|---|
UniProt AC | O43252 | |
Protein Name | Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 | |
Gene Name | PAPSS1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 624 | |
Subcellular Localization | ||
Protein Description | Bifunctional enzyme with both ATP sulfurylase and APS kinase activity, which mediates two steps in the sulfate activation pathway. The first step is the transfer of a sulfate group to ATP to yield adenosine 5'-phosphosulfate (APS), and the second step is the transfer of a phosphate group from ATP to APS yielding 3'-phosphoadenylylsulfate (PAPS: activated sulfate donor used by sulfotransferase). In mammals, PAPS is the sole source of sulfate; APS appears to be only an intermediate in the sulfate-activation pathway. [PubMed: 9576487] | |
Protein Sequence | MEIPGSLCKKVKLSNNAQNWGMQRATNVTYQAHHVSRNKRGQVVGTRGGFRGCTVWLTGLSGAGKTTVSMALEEYLVCHGIPCYTLDGDNIRQGLNKNLGFSPEDREENVRRIAEVAKLFADAGLVCITSFISPYTQDRNNARQIHEGASLPFFEVFVDAPLHVCEQRDVKGLYKKARAGEIKGFTGIDSEYEKPEAPELVLKTDSCDVNDCVQQVVELLQERDIVPVDASYEVKELYVPENKLHLAKTDAETLPALKINKVDMQWVQVLAEGWATPLNGFMREREYLQCLHFDCLLDGGVINLSVPIVLTATHEDKERLDGCTAFALMYEGRRVAILRNPEFFEHRKEERCARQWGTTCKNHPYIKMVMEQGDWLIGGDLQVLDRVYWNDGLDQYRLTPTELKQKFKDMNADAVFAFQLRNPVHNGHALLMQDTHKQLLERGYRRPVLLLHPLGGWTKDDDVPLMWRMKQHAAVLEEGVLNPETTVVAIFPSPMMYAGPTEVQWHCRARMVAGANFYIVGRDPAGMPHPETGKDLYEPSHGAKVLTMAPGLITLEIVPFRVAAYNKKKKRMDYYDSEHHEDFEFISGTRMRKLAREGQKPPEGFMAPKAWTVLTEYYKSLEKA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEIPGSLC -------CCCCCCCC | 10.72 | 22223895 | |
6 | Phosphorylation | --MEIPGSLCKKVKL --CCCCCCCCCEEEC | 25.82 | 25159151 | |
9 | Acetylation | EIPGSLCKKVKLSNN CCCCCCCCEEECCCC | 66.93 | 25953088 | |
9 | Ubiquitination | EIPGSLCKKVKLSNN CCCCCCCCEEECCCC | 66.93 | 23000965 | |
10 | Ubiquitination | IPGSLCKKVKLSNNA CCCCCCCEEECCCCH | 43.54 | 23000965 | |
12 | Acetylation | GSLCKKVKLSNNAQN CCCCCEEECCCCHHH | 55.89 | 25953088 | |
12 | Ubiquitination | GSLCKKVKLSNNAQN CCCCCEEECCCCHHH | 55.89 | 23000965 | |
14 | Phosphorylation | LCKKVKLSNNAQNWG CCCEEECCCCHHHCC | 23.48 | 27251275 | |
26 | Phosphorylation | NWGMQRATNVTYQAH HCCCHHHHCEEEEEE | 32.20 | 21945579 | |
29 | Phosphorylation | MQRATNVTYQAHHVS CHHHHCEEEEEEECC | 16.40 | 21945579 | |
30 | Phosphorylation | QRATNVTYQAHHVSR HHHHCEEEEEEECCC | 10.22 | 21945579 | |
36 | Phosphorylation | TYQAHHVSRNKRGQV EEEEEECCCCCCCCE | 26.27 | 21945579 | |
47 | Methylation | RGQVVGTRGGFRGCT CCCEEECCCCCCCCE | 36.99 | - | |
75 | Phosphorylation | VSMALEEYLVCHGIP HHHHHHHHHHHCCCC | 8.61 | 26074081 | |
84 | Phosphorylation | VCHGIPCYTLDGDNI HHCCCCEEECCCCCH | 12.65 | 26074081 | |
85 | Phosphorylation | CHGIPCYTLDGDNIR HCCCCEEECCCCCHH | 25.70 | 26074081 | |
97 | Ubiquitination | NIRQGLNKNLGFSPE CHHHHHHHCCCCCHH | 59.60 | 29967540 | |
102 | Phosphorylation | LNKNLGFSPEDREEN HHHCCCCCHHHHHHH | 26.11 | 21815630 | |
129 | Phosphorylation | DAGLVCITSFISPYT HCCCEEEEECCCCCC | 16.68 | 28348404 | |
130 | Phosphorylation | AGLVCITSFISPYTQ CCCEEEEECCCCCCC | 10.73 | 28348404 | |
133 | Phosphorylation | VCITSFISPYTQDRN EEEEECCCCCCCCCC | 15.16 | 28348404 | |
150 | Ubiquitination | RQIHEGASLPFFEVF CCCCCCCCCCCEEEE | 47.64 | 27667366 | |
154 | Ubiquitination | EGASLPFFEVFVDAP CCCCCCCEEEEECCC | 8.06 | 24816145 | |
162 | Ubiquitination | EVFVDAPLHVCEQRD EEEECCCHHHHHCCC | 5.18 | 23000965 | |
171 | Ubiquitination | VCEQRDVKGLYKKAR HHHCCCHHHHHHHHH | 47.70 | 27667366 | |
175 | Ubiquitination | RDVKGLYKKARAGEI CCHHHHHHHHHHCCC | 45.03 | 24816145 | |
183 | Neddylation | KARAGEIKGFTGIDS HHHHCCCCCCCCCCC | 43.60 | 32015554 | |
183 | Ubiquitination | KARAGEIKGFTGIDS HHHHCCCCCCCCCCC | 43.60 | 23000965 | |
183 | Acetylation | KARAGEIKGFTGIDS HHHHCCCCCCCCCCC | 43.60 | 26051181 | |
190 | Phosphorylation | KGFTGIDSEYEKPEA CCCCCCCCCCCCCCC | 39.91 | 28796482 | |
192 | Phosphorylation | FTGIDSEYEKPEAPE CCCCCCCCCCCCCCC | 32.95 | 28796482 | |
194 | Ubiquitination | GIDSEYEKPEAPELV CCCCCCCCCCCCCEE | 47.45 | 29967540 | |
231 | Phosphorylation | DIVPVDASYEVKELY CCCCCCCCCEEEEEE | 19.84 | 28152594 | |
232 | Phosphorylation | IVPVDASYEVKELYV CCCCCCCCEEEEEEC | 26.85 | 28152594 | |
235 | Ubiquitination | VDASYEVKELYVPEN CCCCCEEEEEECCCC | 30.02 | 29967540 | |
243 | Acetylation | ELYVPENKLHLAKTD EEECCCCCEEECCCC | 35.30 | 26822725 | |
243 | Ubiquitination | ELYVPENKLHLAKTD EEECCCCCEEECCCC | 35.30 | 32015554 | |
258 | Ubiquitination | AETLPALKINKVDMQ HHHCCCCCCCCCCHH | 46.47 | 32142685 | |
258 | Acetylation | AETLPALKINKVDMQ HHHCCCCCCCCCCHH | 46.47 | 25953088 | |
354 | Methylation | RKEERCARQWGTTCK HHHHHHHHHHCCCCC | 36.09 | 115383527 | |
361 | Ubiquitination | RQWGTTCKNHPYIKM HHHCCCCCCCHHEEE | 57.08 | 29967540 | |
383 | Ubiquitination | LIGGDLQVLDRVYWN EECCCEEEEEEEECC | 8.58 | 27667366 | |
404 | Ubiquitination | RLTPTELKQKFKDMN ECCHHHHHHHHHHCC | 45.25 | 33845483 | |
406 | Ubiquitination | TPTELKQKFKDMNAD CHHHHHHHHHHCCCC | 53.44 | - | |
466 | Sulfoxidation | KDDDVPLMWRMKQHA CCCCCCCHHHHHHHH | 1.42 | 30846556 | |
518 | Phosphorylation | MVAGANFYIVGRDPA EECCCCEEEEECCCC | 8.43 | 20068231 | |
532 | Phosphorylation | AGMPHPETGKDLYEP CCCCCCCCCCCCCCC | 54.72 | 24719451 | |
537 | Phosphorylation | PETGKDLYEPSHGAK CCCCCCCCCCCCCCE | 35.61 | 27642862 | |
537 | Nitration | PETGKDLYEPSHGAK CCCCCCCCCCCCCCE | 35.61 | - | |
547 | Ubiquitination | SHGAKVLTMAPGLIT CCCCEEEEECCCEEE | 17.80 | 24816145 | |
567 | 2-Hydroxyisobutyrylation | FRVAAYNKKKKRMDY EEHHHCCCCCCCCCC | 53.98 | - | |
568 | Ubiquitination | RVAAYNKKKKRMDYY EHHHCCCCCCCCCCC | 60.95 | 24816145 | |
574 | Phosphorylation | KKKKRMDYYDSEHHE CCCCCCCCCCCCCCC | 10.38 | 26846344 | |
575 | Phosphorylation | KKKRMDYYDSEHHED CCCCCCCCCCCCCCC | 14.55 | 26846344 | |
577 | Phosphorylation | KRMDYYDSEHHEDFE CCCCCCCCCCCCCCC | 23.78 | 26846344 | |
587 | Phosphorylation | HEDFEFISGTRMRKL CCCCCCCCCHHHHHH | 39.16 | 26846344 | |
589 | Phosphorylation | DFEFISGTRMRKLAR CCCCCCCHHHHHHHH | 17.94 | 26846344 | |
598 | Ubiquitination | MRKLAREGQKPPEGF HHHHHHCCCCCCCCC | 34.95 | 21890473 | |
600 | Acetylation | KLAREGQKPPEGFMA HHHHCCCCCCCCCCC | 73.69 | 19829777 | |
602 | Ubiquitination | AREGQKPPEGFMAPK HHCCCCCCCCCCCCH | 62.47 | 21890473 | |
609 | Acetylation | PEGFMAPKAWTVLTE CCCCCCCHHHHHHHH | 47.20 | 19829785 | |
619 | Ubiquitination | TVLTEYYKSLEKA-- HHHHHHHHHHHCC-- | 47.89 | 23000965 | |
619 | Ubiquitination | TVLTEYYKSLEKA-- HHHHHHHHHHHCC-- | 47.89 | 21890473 | |
623 | Ubiquitination | EYYKSLEKA------ HHHHHHHCC------ | 65.77 | 23000965 | |
623 | Ubiquitination | EYYKSLEKA------ HHHHHHHCC------ | 65.77 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PAPS1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PAPS1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PAPS1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
EF1A1_HUMAN | EEF1A1 | physical | 16169070 | |
U119A_HUMAN | UNC119 | physical | 16169070 | |
PUR9_HUMAN | ATIC | physical | 22863883 | |
HMGB3_HUMAN | HMGB3 | physical | 22863883 | |
MTRR_HUMAN | MTRR | physical | 22863883 | |
LIS1_HUMAN | PAFAH1B1 | physical | 22863883 | |
PTMA_HUMAN | PTMA | physical | 22863883 | |
PAPS2_HUMAN | PAPSS2 | physical | 28514442 | |
TFCP2_HUMAN | TFCP2 | physical | 28514442 | |
GNL1_HUMAN | GNL1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...